The purpose of this study is to identify changes in heart tissue structure and biological function in patients with heart failure by performing an endomyocardial biopsy (EMB or heart biopsy) during a right heart catheterization (RHC). The ultimate goal is to use this information to develop new treatments for heart failure.
The purpose of this study is to identify changes in heart tissue structure and biological function in patients with heart failure by performing an endomyocardial biopsy (EMB or heart biopsy) during a right heart catheterization (RHC). The ultimate goal is to use this information to develop new treatments for heart failure.
Myocardial Mechanisms in Heart Failure With Preserved Ejection Fraction
-
Northwestern University, Chicago, Illinois, United States, 60611
Johns Hopkins University, Baltimore, Maryland, United States, 21287
Mass General Brigham, Boston, Massachusetts, United States, 02114
Mayo Clinic, Rochester, Minnesota, United States, 55905
Wake Forest University, Winston-Salem, North Carolina, United States, 27157
University of Pennsylvania, Philadelphia, Pennsylvania, United States, 19104
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
30 Years to
ALL
Yes
Northwestern University,
Sanjiv Shah, MD, PRINCIPAL_INVESTIGATOR, Northwestern University
Margaret Redfield, MD, PRINCIPAL_INVESTIGATOR, Mayo Clinic
2026-06